Drug Profile
Research programme: anti-infectives - PharmLogic/University of Pennsylvania
Latest Information Update: 28 Jul 2018
Price :
$50
*
At a glance
- Originator University of Pennsylvania
- Developer PharmLogic; University of Pennsylvania
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Infections
Most Recent Events
- 28 Jul 2018 No recent reports of development identified for research development in Infections in USA
- 13 Jul 2016 Early research is ongoing in USA